journal article·2023-08

Emergency Treatment and Photoacoustic Assessment of Spinal Cord Injury Using Reversible Dual‐Signal Transform‐Based Selenium Antioxidant

Zhisheng Ji, Judun Zheng, Yanming Ma, Hongyi Lei, Weiqiang Lin, Jialin Huang, Hua Yang, Guowei Zhang, Bin Li, Bowen Shu, Xianjin Du, Jian Zhang, Hongsheng Lin, Yuhui Liao

Small· Volume 19· Issue 35
Publisher page

Abstract

Abstract Spinal cord injury (SCI), following explosive oxidative stress, causes an abrupt and irreversible pathological deterioration of the central nervous system. Thus, preventing secondary injuries caused by reactive oxygen species (ROS), as well as monitoring and assessing the recovery from SCI are critical for the emergency treatment of SCI. Herein, an emergency treatment strategy is developed for SCI based on the selenium (Se) matrix antioxidant system to effectively inhibit oxidative stress‐induced damage and simultaneously real‐time evaluate the severity of SCI using a reversible dual‐photoacoustic signal (680 and 750 nm). Within the emergency treatment and photoacoustic severity assessment (ETPSA) strategy, the designed Se loaded boron dipyrromethene dye with a double hydroxyl group (Se@BDP‐DOH) is simultaneously used as a sensitive reporter group and an excellent antioxidant for effectively eliminating explosive oxidative stress. Se@BDP‐DOH is found to promote the recovery of both spinal cord tissue and locomotor function in mice with SCI. Furthermore, ETPSA strategy synergistically enhanced ROS consumption via the caveolin 1 (Cav 1)‐related pathways, as confirmed upon treatment with Cav 1 siRNA. Therefore, the ETPSA strategy is a potential tool for improving emergency treatment and photoacoustic assessment of SCI.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Spinal Cord Injury Research · Perovskite Materials and Applications · Aortic Disease and Treatment Approaches

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedics The First Affiliated Hospital of Jinan University Guangzhou 510630 P. R. China

Molecular Diagnosis and Treatment Center for Infectious Diseases Dermatology Hospital Southern Medical University Guangzhou 510091 P. R. China

Department of Anesthesiology Longgang District Central Hospital of Shenzhen Shenzhen 518100 P. R. China

Department of Critical Care Medicine Renmin Hospital of Wuhan University Wuhan Hubei 430060 P. R. China

Department of Biomedical Engineering School of Basic Medical Science Guang‐zhou Medical University Guangzhou 511436 P. R. China

NHC Key Laboratory of Metabolic Cardiovascular Diseases Research Ningxia Key Laboratory of Vascular Injury and Repair Research Ningxia Medical University Yinchuan 750004 P. R. China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China · Natural Science Foundation of Guangdong Province for Distinguished Young Scholars · National Science Foundation

References (53)

Show source-provided references
1. 10.1038/nrdp.2017.1810.1038/nrdp.2017.18 ↗
2. 10.1016/S1474-4422(20)30406-310.1016/S1474-4422(20)30406-3 ↗
3. 10.1021/acsbiomaterials.0c0119010.1021/acsbiomaterials.0c01190 ↗
4. 10.1038/s41582-019-0270-510.1038/s41582-019-0270-5 ↗
5. 10.1016/j.redox.2015.12.01110.1016/j.redox.2015.12.011 ↗
6. 10.1038/sc.2013.7110.1038/sc.2013.71 ↗
7. 10.1039/C6CS00192K10.1039/C6CS00192K ↗
8. 10.1002/anie.20190679310.1002/anie.201906793 ↗
9. 10.1021/acs.accounts.9b0030210.1021/acs.accounts.9b00302 ↗
10. 10.1002/anie.20200542910.1002/anie.202005429 ↗
11. 10.1073/pnas.180493211510.1073/pnas.1804932115 ↗
12. 10.1016/S0140-6736(02)07603-110.1016/S0140-6736(02)07603-1 ↗
13. 10.1093/brain/awaa36010.1093/brain/awaa360 ↗
14. 10.1002/anie.20170598910.1002/anie.201705989 ↗
15. 10.1002/advs.20220499910.1002/advs.202204999 ↗
16. 10.1186/s12951-022-01490-x10.1186/s12951-022-01490-x ↗
17. 10.1039/C8TB02520G10.1039/C8TB02520G ↗
18. 10.2147/IJN.S28694810.2147/IJN.S286948 ↗
19. 10.4103/1673-5374.33059010.4103/1673-5374.330590 ↗
20. 10.1038/sc.2011.11110.1038/sc.2011.111 ↗
21. 10.1021/acschemneuro.1c0039010.1021/acschemneuro.1c00390 ↗
22. 10.1186/s12974-019-1451-210.1186/s12974-019-1451-2 ↗
23. 10.1002/anie.20210590510.1002/anie.202105905 ↗
24. 10.1002/smll.20220255810.1002/smll.202202558 ↗
25. 10.1021/jacs.9b1035310.1021/jacs.9b10353 ↗
26. 10.1038/s41580-020-0230-310.1038/s41580-020-0230-3 ↗
27. 10.1002/adhm.20210059810.1002/adhm.202100598 ↗
28. 10.1111/j.1744-7909.2007.00600.x10.1111/j.1744-7909.2007.00600.x ↗
29. 10.1038/s41467-021-22686-z10.1038/s41467-021-22686-z ↗
30. 10.1021/acsomega.8b0170610.1021/acsomega.8b01706 ↗
31. 10.1002/ana.41044051410.1002/ana.410440514 ↗
32. 10.1016/j.ccr.2020.21360110.1016/j.ccr.2020.213601 ↗
33. 10.1093/brain/awab20310.1093/brain/awab203 ↗
34. 10.1002/adhm.20210059810.1002/adhm.202100598 ↗
35. 10.1186/s12974-018-1387-y10.1186/s12974-018-1387-y ↗
36. 10.1016/j.biomaterials.2022.12148110.1016/j.biomaterials.2022.121481 ↗
37. 10.1016/j.scib.2022.10.02510.1016/j.scib.2022.10.025 ↗
38. 10.1016/S0168-8278(99)80018-X10.1016/S0168-8278(99)80018-X ↗
39. 10.1038/s41467-020-15889-310.1038/s41467-020-15889-3 ↗
40. 10.1016/j.biomaterials.2010.01.06510.1016/j.biomaterials.2010.01.065 ↗
41. 10.1002/smll.20090000510.1002/smll.200900005 ↗
42. 10.3727/096368914X68282810.3727/096368914X682828 ↗
43. 10.1038/s41413-022-00199-910.1038/s41413-022-00199-9 ↗
44. 10.1016/j.bioactmat.2022.04.02910.1016/j.bioactmat.2022.04.029 ↗
45. 10.1002/anie.20191061510.1002/anie.201910615 ↗
46. 10.1002/btm2.1036010.1002/btm2.10360 ↗
47. Wu X. · J. Neurotraum. · 2019 · 36 · 460
48. 10.1155/2014/43158010.1155/2014/431580 ↗
49. 10.1523/JNEUROSCI.2349-11.201110.1523/JNEUROSCI.2349-11.2011 ↗
50. 10.1111/jnc.1223010.1111/jnc.12230 ↗
51. 10.1016/j.omtn.2022.11.02510.1016/j.omtn.2022.11.025 ↗
52. 10.7150/thno.7432410.7150/thno.74324 ↗
53. 10.4103/1673-5374.19714510.4103/1673-5374.197145 ↗